TEAS Plus New Application

AMLYPAVE

Alexion Pharmaceuticals, Inc.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 97068238
Filing Date: 10/11/2021

NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular application.


The table below presents the data as entered.

Input Field
Entered
TEAS Plus YES
MARK INFORMATION
*MARK AMLYPAVE
*STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT AMLYPAVE
*MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Alexion Pharmaceuticals, Inc.
*MAILING ADDRESS 121 Seaport Boulevard
*CITY Boston
*STATE
(Required for U.S. applicants)
Massachusetts
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
02210
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
*TYPE CORPORATION
* STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
*INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations for the treatment of inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, protein aggregation-related diseases and disorders, neurodegenerative diseases and disorders
*FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS INFORMATION
*TRANSLATION
(if applicable)
 
*TRANSLITERATION
(if applicable)
 
*CLAIMED PRIOR REGISTRATION
(if applicable)
 
*CONSENT (NAME/LIKENESS)
(if applicable)
 
*CONCURRENT USE CLAIM
(if applicable)
 
ATTORNEY INFORMATION
NAME Maury M. Tepper, III
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Tepper & Eyster, PLLC
STREET 3724 Benson Drive
CITY Raleigh
STATE North Carolina
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 27609
PHONE 919-861-8903
FAX 919-861-8913
EMAIL ADDRESS mtepper@teiplaw.com
OTHER APPOINTED ATTORNEY Kathryn M. Eyster
CORRESPONDENCE INFORMATION
NAME Maury M. Tepper, III
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE mtepper@teiplaw.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) tmorris@teiplaw.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Plus
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 250
*TOTAL FEES DUE 250
*TOTAL FEES PAID 250
SIGNATURE INFORMATION
* SIGNATURE /Laural S Boone/
* SIGNATORY'S NAME Laural Boone
* SIGNATORY'S POSITION Senior Director
* DATE SIGNED 10/11/2021
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 97068238
Filing Date: 10/11/2021

To the Commissioner for Trademarks:

MARK: AMLYPAVE (Standard Characters, see mark)
The literal element of the mark consists of AMLYPAVE. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Alexion Pharmaceuticals, Inc., a corporation of Delaware, having an address of
      121 Seaport Boulevard
      Boston, Massachusetts 02210
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

For specific filing basis information for each item, you must view the display within the Input Table.
International Class 005:  Pharmaceutical preparations for the treatment of inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, protein aggregation-related diseases and disorders, neurodegenerative diseases and disorders
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services. (15 U.S.C. Section 1051(b)).



The owner's/holder's proposed attorney information: Maury M. Tepper, III. Other appointed attorneys are Kathryn M. Eyster. Maury M. Tepper, III of Tepper & Eyster, PLLC, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      3724 Benson Drive
      Raleigh, North Carolina 27609
      United States
      919-861-8903(phone)
      919-861-8913(fax)
      mtepper@teiplaw.com

Maury M. Tepper, III submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Maury M. Tepper, III
       PRIMARY EMAIL FOR CORRESPONDENCE: mtepper@teiplaw.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): tmorris@teiplaw.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $250 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Laural S Boone/   Date: 10/11/2021
Signatory's Name: Laural Boone
Signatory's Position: Senior Director
Signature method: Sent to third party for signature
Payment Sale Number: 97068238
Payment Accounting Date: 10/12/2021

Serial Number: 97068238
Internet Transmission Date: Mon Oct 11 12:33:35 ET 2021
TEAS Stamp: USPTO/FTK-XXXX:XXXX:XXXX:XXXX:XXXX:XXXX:
XXXX:XXXX-20211011123335474633-97068238-
781f582d6ad25c4890f9ee914946f8a63881a990
555261bc3376b686226b9915-CC-33340680-202
11008151101485849

TEAS Plus New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed